Pharmaceutical Technology® spoke with Nicola Reid, Associate Director Product Management, Endotoxin Products at Charles River Laboratories, to get her perspective on endotoxin testing and USP’s new ...

The US Pharmacopeia’s Microbiology Expert Committee approved the inclusion of a chapter into the United States Pharmacopeia–National Formulary that allows the use of non-animal-derived reagents for ...

This webinar will help the attendee gain an understanding of the requirements of current USP <85> Bacterial Endotoxin Test (BET) European Pharmacopoeia (Chapter 2.6.14) and the Japanese Pharmacopoeia ...

Surf on a beach at sunset features a horseshoe crab upside down in the water and several others nearby. Regulatory changes may make the pharmaceutical industry less reliant on horseshoe crabs for ...

Ensuring the safety of medical products, such as drugs, biologics, or devices, requires careful testing for contaminants. Bacterial endotoxins are a major concern for pharmaceutical manufacturers ...

AGAWAM, Mass., Oct. 24, 2012 /PRNewswire/ -- A new white paper is available to assist medical device manufacturers with understanding recent changes to the U.S. Food and Drug Administration's (FDA) ...

DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...

The novel Sievers Eclipse BET platform reduces endotoxin assay setup time by as much as 85% and decreases the use of Limulus Amebocyte Lysate (LAL) reagent by up to 90%. At the same time, it fulfills ...

Associates of Cape Cod, Inc., (ACC), one of the world's largest manufacturers of products developed to detect and quantify gram-negative bacterial endotoxins and (1?3)-ß-D-glucans, has introduced a ...

In the pharmaceutical industry, ensuring product safety and efficacy is paramount. Therefore, rigorous testing and analysis procedures are employed to ensure that pharmaceutical products meet the ...